ROBO Global Healthcare Technology and Innovation ETF Rating $29.76 -0.64 (-2.11%) Closing price 02/21/2025 04:10 PM EasternExtended Trading$30.33 +0.57 (+1.92%) As of 02/21/2025 05:24 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHeadlinesHoldingsOwnershipRatings ROBO Global Healthcare Technology and Innovation ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.HTEC Aggregate RatingModerate Buy 2.68Holdings in HTEC have an aggregate rating of Moderate Buy based on 605 analyst ratings issued in the past year covering 42 companies (68.2% of the portfolio).HTEC Aggregate Price Target$29.76High Prediction$29.76Average Prediction$29.76Low Prediction$29.76Holdings in HTEC have an aggregate price target of $29.76 and a range of $29.76 to $29.76 covering 42 companies (68.2% of the portfolio).HTEC Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy6 Buy rating(s)Moderate Buy28 Moderate Buy rating(s)Hold7 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by ROBO Global Healthcare Technology and Innovation ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 42 HTEC Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings2.45%TEMTempus AI$68.09-11.2%1.3861 of 5 stars2.67$58.55 -14.0%12Insider TradeGap Up2.29%GHGuardant Health$42.87-9.6%4.2116 of 5 stars3.00$44.78 4.5%18Earnings ReportAnalyst ForecastNews CoverageGap UpHigh Trading Volume2.22%AXGNAxoGen$18.00-2.7%1.0485 of 5 stars3.00$18.33 1.9%3News Coverage2.19%BSXBoston Scientific$104.44-0.9%4.4874 of 5 stars3.00$107.39 2.8%23Analyst DowngradeInsider TradePositive News2.16%GRALGrail$40.73-14.7%0.9984 of 5 stars2.00$16.00 -60.7%3Earnings ReportNews CoverageGap Up1.99%ISRGIntuitive Surgical$591.79-2.4%4.5247 of 5 stars2.71$613.10 3.6%21Positive News1.93%ALNYAlnylam Pharmaceuticals$250.59-0.2%4.4399 of 5 stars2.72$299.48 19.5%25Analyst ForecastInsider Trade1.93%PENPenumbra$292.52-3.5%4.4483 of 5 stars2.88$292.64 0.0%16Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage1.89%TMOThermo Fisher Scientific$532.55-1.0%4.7267 of 5 stars2.82$656.86 23.3%22Dividend IncreaseAnalyst RevisionPositive News1.86%SYKStryker$382.59-1.0%4.9452 of 5 stars2.80$422.15 10.3%20Analyst ForecastInsider TradeAnalyst RevisionPositive News1.86%IRTCiRhythm Technologies$119.58+6.1%1.1217 of 5 stars2.82$115.55 -3.4%11Earnings ReportAnalyst ForecastNews CoverageGap UpHigh Trading Volume1.86%NTRANatera$162.31-3.5%2.5772 of 5 stars3.00$170.94 5.3%16Positive News1.82%VRTXVertex Pharmaceuticals$484.24+0.8%4.0991 of 5 stars2.65$506.70 4.6%26Analyst DowngradeInsider TradeAnalyst RevisionPositive News1.72%ABTAbbott Laboratories$135.04+1.4%4.8932 of 5 stars2.83$133.06 -1.5%18Dividend AnnouncementPositive News1.71%EWEdwards Lifesciences$73.25-2.0%4.4921 of 5 stars2.42$79.95 9.1%26Positive News1.66%IQVIQVIA$190.94-1.6%4.9634 of 5 stars2.90$251.22 31.6%21Analyst ForecastPositive News1.64%DHRDanaher$209.86+0.9%4.992 of 5 stars2.71$278.00 32.5%21Dividend IncreaseAnalyst RevisionPositive News1.57%AZTAAzenta$44.75-0.1%3.5014 of 5 stars2.50$58.75 31.3%4Positive News1.57%AORTArtivion$28.29-1.8%1.4337 of 5 stars3.00$31.80 12.4%51.55%AAgilent Technologies$135.33-1.1%4.0867 of 5 stars2.50$144.38 6.7%14Upcoming EarningsDividend AnnouncementNews CoveragePositive News1.52%GEHCGE HealthCare Technologies$91.09-1.1%3.2505 of 5 stars2.69$97.67 7.2%13Positive News1.49%CRLCharles River Laboratories International$163.11+0.5%4.7799 of 5 stars1.88$195.71 20.0%16Earnings ReportAnalyst ForecastInsider TradeAnalyst RevisionNews Coverage1.48%MEDPMedpace$340.78-1.2%4.254 of 5 stars2.45$381.44 11.9%111.46%REGNRegeneron Pharmaceuticals$700.33+0.6%4.7594 of 5 stars2.76$973.13 39.0%25Dividend Announcement1.46%INCYIncyte$72.05+0.9%4.5303 of 5 stars2.35$75.59 4.9%201.45%DXCMDexCom$88.78-0.6%4.739 of 5 stars2.94$99.06 11.6%18Positive News1.45%GKOSGlaukos$126.03-19.9%4.3902 of 5 stars2.92$163.25 29.5%13Earnings ReportAnalyst UpgradeInsider TradeNews CoverageGap DownHigh Trading Volume1.39%BDXBecton, Dickinson and Company$227.54-0.2%4.9181 of 5 stars3.00$278.29 22.3%7Positive News1.37%NOVTNovanta$140.51-1.6%2.0765 of 5 stars2.00$169.00 20.3%1Upcoming EarningsNews Coverage1.36%OMCLOmnicell$39.72+0.2%3.8469 of 5 stars2.33$52.33 31.8%6Positive News1.36%BIOBio-Rad Laboratories$279.48-2.2%4.7938 of 5 stars2.60$395.20 41.4%51.36%CRSPCRISPR Therapeutics$47.91-5.0%3.157 of 5 stars2.50$74.40 55.3%22Analyst ForecastInsider TradeOptions VolumeAnalyst Revision1.35%CDNACareDx$22.29-4.7%3.7089 of 5 stars2.57$28.33 27.1%7Upcoming EarningsAnalyst DowngradeNews Coverage1.35%ARWRArrowhead Pharmaceuticals$19.90-5.1%4.0859 of 5 stars2.60$41.44 108.3%101.34%QGENQiagen$39.52+2.5%4.4256 of 5 stars2.30$47.71 20.7%10Analyst Downgrade1.34%UTHRUnited Therapeutics$361.10-1.7%4.3595 of 5 stars2.67$388.25 7.5%12Insider TradePositive News1.34%MASIMasimo$169.96-4.1%3.594 of 5 stars2.83$191.40 12.6%6Analyst RevisionNews Coverage1.31%ILMNIllumina$94.20-3.1%4.7705 of 5 stars2.62$159.45 69.3%211.31%ALGNAlign Technology$190.43-3.9%4.7881 of 5 stars2.77$269.91 41.7%131.30%VCYTVeracyte$39.18-4.6%2.9221 of 5 stars2.67$42.00 7.2%9Analyst DowngradeNews Coverage1.28%GMEDGlobus Medical$80.43-4.4%4.834 of 5 stars2.75$96.91 20.5%12Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageHigh Trading Volume1.27%BMRNBioMarin Pharmaceutical$68.25-0.7%4.9101 of 5 stars2.70$93.81 37.4%23Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage This page (NYSEARCA:HTEC) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredThe Real Hillbilly ElegyThe mountains of Appalachia are incredible to behold. Spanning thousands of miles across Alabama, Kentucky...Porter & Company | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon Social Security shock?“A Maniacal Sense of Urgency” We could be just days away from Elon Musk launching his next big venture. One...Altimetry | SponsoredMajor AI announcement for 2025BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI StocksBrownstone Research | SponsoredHas Trump finally met his match?A new Chinese AI software called "DeepSeek" is sending shockwaves through the market. It's advanced enough ...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ROBO Global Healthcare Technology and Innovation ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share ROBO Global Healthcare Technology and Innovation ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
